Mitchell Cheung

4.0k total citations · 1 hit paper
28 papers, 2.7k citations indexed

About

Mitchell Cheung is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Mitchell Cheung has authored 28 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 14 papers in Pulmonary and Respiratory Medicine and 6 papers in Oncology. Recurrent topics in Mitchell Cheung's work include Occupational and environmental lung diseases (14 papers), Medical Imaging and Pathology Studies (8 papers) and PI3K/AKT/mTOR signaling in cancer (7 papers). Mitchell Cheung is often cited by papers focused on Occupational and environmental lung diseases (14 papers), Medical Imaging and Pathology Studies (8 papers) and PI3K/AKT/mTOR signaling in cancer (7 papers). Mitchell Cheung collaborates with scholars based in United States, Italy and Portugal. Mitchell Cheung's co-authors include Joseph R. Testa, Gavin P. Robertson, Arati Sharma, Jianming Pei, Eleonora Sementino, Yinfei Tan, Jin Q. Cheng, Mark Kester, Lakshman Sandirasegarane and Marcus Bosenberg and has published in prestigious journals such as Journal of Biological Chemistry, Nature Genetics and Cancer Research.

In The Last Decade

Mitchell Cheung

28 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Germline BAP1 mutations predispose to malignant mesothelioma

2011 719 citations Joseph R. Testa, Mitchell Cheung et al. Nature Genetics profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mitchell Cheung United States	21	1.5k	987	720	404	287	28	2.7k
Sara Piccinin Italy	22	2.3k 1.5×	584 0.6×	1.4k 2.0×	628 1.6×	256 0.9×	29	3.4k
Arnulfo Mendoza United States	26	1.5k 1.0×	789 0.8×	965 1.3×	636 1.6×	357 1.2×	51	2.8k
Jung-Sik Kim United States	26	1.5k 1.0×	313 0.3×	596 0.8×	406 1.0×	154 0.5×	45	2.2k
Bungo Furusato United States	26	1.1k 0.7×	1.4k 1.4×	759 1.1×	618 1.5×	204 0.7×	63	2.7k
Shi‐Ming Tu United States	19	857 0.6×	1.1k 1.1×	781 1.1×	397 1.0×	147 0.5×	72	2.1k
Marya F. McCarty United States	29	2.0k 1.3×	285 0.3×	1.1k 1.6×	869 2.2×	436 1.5×	37	3.0k
Kim L. Mercer United States	10	2.6k 1.7×	532 0.5×	1.6k 2.2×	737 1.8×	399 1.4×	15	3.9k
Cammie Rinehart United States	15	1.7k 1.1×	567 0.6×	1.7k 2.3×	327 0.8×	208 0.7×	19	2.8k
Seung Myung Dong South Korea	31	2.0k 1.3×	250 0.3×	937 1.3×	784 1.9×	260 0.9×	49	3.0k
Paul Meltzer United States	7	1.8k 1.2×	235 0.2×	768 1.1×	824 2.0×	233 0.8×	10	2.4k

Countries citing papers authored by Mitchell Cheung

Since Specialization

Citations

This map shows the geographic impact of Mitchell Cheung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mitchell Cheung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mitchell Cheung more than expected).

Fields of papers citing papers by Mitchell Cheung

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mitchell Cheung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mitchell Cheung. The network helps show where Mitchell Cheung may publish in the future.

Co-authorship network of co-authors of Mitchell Cheung

This figure shows the co-authorship network connecting the top 25 collaborators of Mitchell Cheung. A scholar is included among the top collaborators of Mitchell Cheung based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mitchell Cheung. Mitchell Cheung is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Menges, Craig W., et al.. (2024). Alterations of the AKT Pathway in Sporadic Human Tumors, Inherited Susceptibility to Cancer, and Overgrowth Syndromes. Current topics in microbiology and immunology. 1 indexed citations

Peng, Hongzhuang, Joel Cassel, Jeremy W. Prokop, et al.. (2021). Kinetic Characterization of ASXL1/2-Mediated Allosteric Regulation of the BAP1 Deubiquitinase. Molecular Cancer Research. 19(7). 1099–1112. 4 indexed citations

Tan, Yinfei, Eleonora Sementino, Mitchell Cheung, et al.. (2020). Somatic Epigenetic Silencing of RIPK3 Inactivates Necroptosis and Contributes to Chemoresistance in Malignant Mesothelioma. Clinical Cancer Research. 27(4). 1200–1213. 38 indexed citations

Sementino, Eleonora, Yuwaraj Kadariya, Craig W. Menges, et al.. (2019). Inactivation of Bap1 Cooperates with Losses of Nf2 and Cdkn2a to Drive the Development of Pleural Malignant Mesothelioma in Conditional Mouse Models. Cancer Research. 79(16). 4113–4123. 41 indexed citations

Peng, Hongzhuang, Jeremy W. Prokop, Jayashree Karar, et al.. (2017). Familial and Somatic BAP1 Mutations Inactivate ASXL1/2-Mediated Allosteric Regulation of BAP1 Deubiquitinase by Targeting Multiple Independent Domains. Cancer Research. 78(5). 1200–1213. 20 indexed citations

Cheung, Mitchell & Joseph R. Testa. (2017). BAP1, a tumor suppressor gene driving malignant mesothelioma. Translational Lung Cancer Research. 6(3). 270–278. 48 indexed citations

Ohar, Jill, Mitchell Cheung, Jacqueline Talarchek, et al.. (2016). Germline BAP1 Mutational Landscape of Asbestos-Exposed Malignant Mesothelioma Patients with Family History of Cancer. Cancer Research. 76(2). 206–215. 64 indexed citations

Kadariya, Yuwaraj, Craig W. Menges, Jacqueline Talarchek, et al.. (2016). Inflammation-Related IL1β/IL1R Signaling Promotes the Development of Asbestos-Induced Malignant Mesothelioma. Cancer Prevention Research. 9(5). 406–414. 59 indexed citations

Kadariya, Yuwaraj, Mitchell Cheung, Jinfei Xu, et al.. (2016). Bap1 Is a Bona Fide Tumor Suppressor: Genetic Evidence from Mouse Models Carrying Heterozygous Germline Bap1 Mutations. Cancer Research. 76(9). 2836–2844. 79 indexed citations

10.

Cheung, Mitchell, Yuwaraj Kadariya, Jacqueline Talarchek, et al.. (2015). Germline BAP1 mutation in a family with high incidence of multiple primary cancers and a potential gene–environment interaction. Cancer Letters. 369(2). 261–265. 33 indexed citations

11.

Cheung, Mitchell, Yuwaraj Kadariya, Jianming Pei, et al.. (2015). An asbestos-exposed family with multiple cases of pleural malignant mesothelioma without inheritance of a predisposing BAP1 mutation. Cancer Genetics. 208(10). 502–507. 10 indexed citations

12.

Kalra, Neetu, Jingli Zhang, Anish Thomas, et al.. (2015). Mesothelioma patient derived tumor xenografts with defined BAP1 mutations that mimic the molecular characteristics of human malignant mesothelioma. BMC Cancer. 15(1). 376–376. 21 indexed citations

13.

Xu, Jinfei, Yuwaraj Kadariya, Mitchell Cheung, et al.. (2014). Germline Mutation of Bap1 Accelerates Development of Asbestos-Induced Malignant Mesothelioma. Cancer Research. 74(16). 4388–4397. 107 indexed citations

14.

Thapa, Roshan J., Peirong Chen, Mitchell Cheung, et al.. (2013). NF-κB Inhibition by Bortezomib Permits IFN-γ–Activated RIP1 Kinase–Dependent Necrosis in Renal Cell Carcinoma. Molecular Cancer Therapeutics. 12(8). 1568–1578. 19 indexed citations

15.

Cheung, Mitchell, et al.. (2013). Further evidence for germline BAP1 mutations predisposing to melanoma and malignant mesothelioma. Cancer Genetics. 206(5). 206–210. 59 indexed citations

16.

Cheung, Mitchell & Joseph R. Testa. (2013). Diverse Mechanisms of AKT Pathway Activation in Human Malignancy. Current Cancer Drug Targets. 13(3). 234–244. 153 indexed citations

17.

Testa, Joseph R., Mitchell Cheung, Jianming Pei, et al.. (2011). Germline BAP1 mutations predispose to malignant mesothelioma. Nature Genetics. 43(10). 1022–1025. 719 indexed citations breakdown →

18.

Tan, Yinfei, Mitchell Cheung, Jianming Pei, et al.. (2010). Upregulation of DLX5 Promotes Ovarian Cancer Cell Proliferation by Enhancing IRS-2-AKT Signaling. Cancer Research. 70(22). 9197–9206. 51 indexed citations

19.

Altomare, Deborah A., Susanna M. Rybak, Jianming Pei, et al.. (2010). Onconase responsive genes in human mesothelioma cells: implications for an RNA damaging therapeutic agent. BMC Cancer. 10(1). 25 indexed citations

20.

Cheung, Mitchell, Jianming Pei, Yangli Pei, et al.. (2009). The promyelocytic leukemia zinc-finger gene, PLZF, is frequently downregulated in malignant mesothelioma cells and contributes to cell survival. Oncogene. 29(11). 1633–1640. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact